Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits
Clinical trial NCT06804044 · COMPLETED
Trial details
- NCT number
- NCT06804044
- Sponsor
- Bahçeşehir University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2023-05-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.